PDGF-BB and the metastatic brain microenvironment
PDGF-BB和转移性脑微环境
基本信息
- 批准号:10718597
- 负责人:
- 金额:$ 48.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-11 至 2028-07-31
- 项目状态:未结题
- 来源:
- 关键词:ANGPT1 geneAblationAngiogenic FactorAngiopoietinsAstrocytesBiologyBlood - brain barrier anatomyBlood VesselsBrainBrain NeoplasmsBreast Cancer CellBreast Cancer PatientBreast Epithelial CellsBreast cancer metastasisCellsCoculture TechniquesCollaborationsComplexCytometryDataDiagnosisDistantEvaluationFibroblastsHumanHyperactivityImmune EvasionIn VitroInjectionsIntracranial NeoplasmsInvestigationKnowledgeLigandsMalignant - descriptorMammary NeoplasmsMediatingMesenchymalMetastatic malignant neoplasm to brainMicrofluidicsMicrogliaMolecularMusMyelogenousMyeloid CellsNeoplasm MetastasisOrganPDGFRB genePatientsPericytesPhagocytesPhenotypePlatelet-Derived Growth FactorPlatelet-Derived Growth Factor ReceptorPlatelet-Derived Growth Factor beta ReceptorPopulationPublishingSignal TransductionSiteSurvival RateTestingTreatment EfficacyTumor PromotionWomanWorkautocrineblood-brain barrier permeabilizationbrain remodelingcancer diagnosiscerebral microvasculatureclinically relevantexperimental studyimmunoregulationin vivoinhibitormalignant breast neoplasmmortalitymouse modelneoplastic cellnovelplatelet-derived growth factor BBprognosticreceptorresponsesmall moleculesmall molecule inhibitortargeted treatmenttherapeutic evaluationtumortumor growthtumor microenvironmenttumor-immune system interactionstumorigenic
项目摘要
PROJECT SUMMARY
Recent studies by my group have highlighted the clinical relevance of platelet-derived growth factor-B
(PDGFB) secreted by malignant breast epithelial cells and its receptor, platelet-derived growth factor receptor
beta (PDGFRβ), expressed on cells of the mesenchymal lineage (e.g., fibroblasts, pericytes, astrocytes) in the
promotion of breast cancer metastasis to the brain (BCBM). Our studies revealed: (1) PDGFB ligand promotes
primary and intracranial breast tumor growth, (2) mesenchymal-specific PDGFRβ hyperactivity (Fsp1-
cre;PdgfrbD849V/+) promotes BCBM in mice, (3) PDGFB ligand expression in the primary breast tumor is
prognostic of brain metastases in human breast cancer patients, and (4) inhibition with a small molecule
selective PDGFR inhibitor (crenolanib) reduces intracranial tumor growth in mouse models of BCBM. This
published work discovered PDGFB-to-PDGFRβ signaling as a clinically relevant signaling node for predicting,
and potentially treating, BCBM. Our continued investigation into how breast cancer-derived PDGFB
mechanistically modulates the brain TME has further revealed previously unknown immuno-modulatory and
vascular effects. The current application will directly test the overarching hypothesis that breast cancer cells
expressing PDGFB completely transform the brain metastatic niche, both by creating a pro-tumorigenic
immune microenvironment and by invoking vascular changes. In Aim 1, the interaction between breast cancer
cells with/without PDGFB and the brain immune microenvironment will be evaluated in vitro (microglial co-
cultures and conditioned media experiments) and in vivo (intracardiac injections followed by brain
histopathological evaluation and high-plex spectral cytometry). This aim will also evaluate if PDGFB causes
changes in the microglial phagocytic response as well as shifts in anti-tumorigenic/pro-tumorigenic myeloid cell
phenotypes. These studies will be the first to directly test whether breast cancer-derived PDGFB drives
immune evasion in the brain metastatic microenvironment. In Aim 2, the interaction between breast cancer
cells with/without PDGFB and the brain microvasculature will be evaluated in vitro (BBB spheroids,
microfluidics) and in vivo (intracardiac injections followed by brain histopathological evaluation). This aim will
also evaluate a putative mechanism by which PDGFB functions in an autocrine manner to upregulate the pro-
angiogenic factor Angiopoietin-1, and whether these vascular changes can be ablated with small molecule
inhibitors of PDGFRβ and/or Tie2 (angiopoietin receptor). These studies will be the first to directly test the
hypothesis that breast cancer-derived PDGFB alters the brain microvasculature indirectly through an autocrine
PDGFB-PDGFRβ-Ang1 axis. Upon completion of the proposed study, we will have determined potentially
targetable mechanism(s) by which PDGFB pre-conditions the brain microenvironment allowing for metastasis
to this site.
项目总结
我的团队最近的研究强调了血小板衍生生长因子-B的临床相关性
恶性乳腺上皮细胞及其受体血小板衍生生长因子受体(PDGFB)的分泌
β(PDGFRβ),表达于骨髓间充质系细胞(如成纤维细胞、周细胞、星形胶质细胞)。
促进乳腺癌脑转移(BCBM)。我们的研究表明:(1)PDGFB配体促进
原发和颅内乳腺肿瘤生长,(2)间充质细胞特异性PDGFRβ过度活动(FSP1-
Cre;PdgfrbD849V/+)促进小鼠BCBM,(3)PDGFB配体在原发乳腺肿瘤中的表达
乳腺癌患者脑转移的预后,以及(4)小分子的抑制作用
选择性PDGFR抑制剂(Crenolanib)减少BCBM小鼠模型中的颅内肿瘤生长。这
已发表的工作发现PDGFB-to-PDGFRβ信号作为临床相关的信令节点用于预测,
和潜在的治疗,BCBM。我们继续调查乳腺癌来源的PDGFB是如何
机械调节大脑TME进一步揭示了先前未知的免疫调节和
血管效应。目前的应用将直接测试乳腺癌细胞的主要假设
表达PDGFB完全改变了脑转移的生态位,这两种方式都是通过创造一种促肿瘤形成
免疫微环境和引发血管变化。在目标1中,乳腺癌之间的相互作用
有/没有PDGFB的细胞和脑免疫微环境将在体外进行评估(小胶质细胞共同
培养和条件培养液实验)和体内(心内注射,然后脑注射
组织病理学评价和高复合光谱分析)。该目标还将评估PDGFB是否会导致
小胶质细胞吞噬反应的变化以及抗肿瘤/促肿瘤髓系细胞的转变
表型。这些研究将是第一次直接测试乳腺癌来源的PDGFB是否会驱动
脑转移微环境中的免疫逃避。在目标2中,乳腺癌之间的相互作用
有/没有PDGFB的细胞和脑微血管系统将在体外进行评估(血脑屏障球体,
微流体)和体内(心内注射,然后进行脑组织病理学评估)。这一目标将
还评估了PDGFB以自分泌方式发挥作用以上调蛋白水平的可能机制。
血管生成因子血管生成素-1及这些血管改变能否被小分子消融
PDGFRβ和/或TIE2(血管生成素受体)的抑制剂。这些研究将是第一个直接测试
乳腺癌来源的PDGFB通过自分泌间接改变脑微血管的假说
PDGFB-PDGFFRβ-Ang1轴。在建议的研究完成后,我们将会确定可能
PDGFB预调节允许转移的脑微环境的靶向机制(S)
到这个网站。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gina Marie Sizemore其他文献
Gina Marie Sizemore的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
心房細動に対するPulsed Field Ablationの組織創傷治癒過程を明らかにする網羅的研究
阐明房颤脉冲场消融组织伤口愈合过程的综合研究
- 批准号:
24K11201 - 财政年份:2024
- 资助金额:
$ 48.75万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
- 批准号:
24K21101 - 财政年份:2024
- 资助金额:
$ 48.75万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
遅延造影心臓MRIによる心房細動Ablation冷却効果の比較:28 vs. 31 mm Cryoballoon
使用延迟对比增强心脏 MRI 比较房颤消融冷却效果:28 毫米与 31 毫米 Cryoballoon
- 批准号:
24K11281 - 财政年份:2024
- 资助金额:
$ 48.75万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
InSPACE-VT_Development and Validation of Virtual Pace Mapping to Guide Catheter Ablation of Ventricular Tachycardia
InSPACE-VT_虚拟起搏测绘的开发和验证以指导室性心动过速导管消融
- 批准号:
EP/Z001145/1 - 财政年份:2024
- 资助金额:
$ 48.75万 - 项目类别:
Fellowship
CAREER: Heat Penetration Depth and Direction Control with Closed-Loop Device for Precision Ablation
职业:利用闭环装置控制热穿透深度和方向,实现精确烧蚀
- 批准号:
2338890 - 财政年份:2024
- 资助金额:
$ 48.75万 - 项目类别:
Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
- 批准号:
2334777 - 财政年份:2024
- 资助金额:
$ 48.75万 - 项目类别:
Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
- 批准号:
2334775 - 财政年份:2024
- 资助金额:
$ 48.75万 - 项目类别:
Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
- 批准号:
2334776 - 财政年份:2024
- 资助金额:
$ 48.75万 - 项目类别:
Continuing Grant
MRI: Acquisition of a Laser Ablation - Inductively Coupled Plasma - Triple Quadrupole - Mass Spectrometer (LA-ICP-QQQ-MS) System For Research and Education
MRI:获取用于研究和教育的激光烧蚀 - 电感耦合等离子体 - 三重四极杆 - 质谱仪 (LA-ICP-MS/MS) 系统
- 批准号:
2320040 - 财政年份:2023
- 资助金额:
$ 48.75万 - 项目类别:
Standard Grant
Collaborative Research: CDS&E: An experimentally validated, interactive, data-enabled scientific computing platform for cardiac tissue ablation characterization and monitoring
合作研究:CDS
- 批准号:
2245152 - 财政年份:2023
- 资助金额:
$ 48.75万 - 项目类别:
Standard Grant